Despite its benefits, 3 Factor PCC has certain limitations. The absence of factor VII might limit its effectiveness in reversing certain types of bleeding. Additionally, the availability and cost of PCC can be a barrier in some healthcare settings. Clinicians must weigh these factors against the clinical urgency and potential outcomes when considering PCC as a therapeutic option.
